Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

On August 31, 2018 Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported that it will present at the 20th Annual Rodman & Renshaw Global Investment Conference at 09:10 AM Eastern Time on Thursday, September 6, 2018 (Press release, Cytori Therapeutics, AUG 31, 2018, View Source;RenshawGlobal-Investment-Conference/default.aspx [SID1234529440]). The presentation will take place in the Fontainebleau Foyer room at the St. Regis New York, in New York, NY. Dr. Marc Hedrick, CEO and President of Cytori Therapeutics, will provide an update on current corporate activities and recent developments. Cytori management will be available for one-on-one meetings at the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!